Pfizer submits application for authorization for COVID-19 booster shots in children five to 11

BREAKING: Pfizer submits application to FDA to obtain authorization for COVID-19 booster shots for children aged five to 11

  • NYC-based Pfizer is bidding to have its COVID-19 vaccine booster shot accepted for children aged five to 11
  • It could be the primary booster shot accessible to that age group, as Pfizer’s jab is the one one the FDA has accepted for minors in the U.S.
  • Some consultants disagree that the shots are obligatory for children this younger, although, because the probability of them struggling a extreme Covid case could be very low 
  • A CDC examine printed Tuesday discovered that 75% of U.S. children have been contaminated with Covid, greater than another age group 


Pfizer, the main producer of COVID-19 vaccines in America, has submitted a bid to the Food and Drug Administration (FDA) to start distributing booster shots for children aged five to 11. 

The New York City-based company made the announcement Tuesday afternoon, additionally revealing outcomes of its Phase 2/3 scientific trials which raised Covid antibody ranges in the age group 36-fold with none critical problems.

If accepted, it might be the primary booster dose accessible to the age group, because the Pfizer-BioNTech shot is the one one accessible to Americans below the age of 18.

Many consultants disagree that the shots are wanted in children of this age, although, with some pointing to the lasting immunity the shots have towards critical an infection – mixed with the restricted threat children face from the virus anyhow.

Earlier on Tuesday, the Centers for Disease Control Prevention (CDC), revealed that round 75 % of U.S. children and teenagers had been contaminated with Covid, with a lowly 1,001 deaths recorded among the many age group.

Pfizer, the nation's leading COVID-19 vaccine manufacturer, has applied for authorization for it booster shot in children aged five to 11 years old. Pictured: A young child in Bowling Green, Kentucky, receives a shot of a COVID-19 vaccine

Pfizer, the nation’s main COVID-19 vaccine producer, has utilized for authorization for it booster shot in children aged five to 11 years outdated. Pictured: A younger youngster in Bowling Green, Kentucky, receives a shot of a COVID-19 vaccine

Trials carried out by Pfizer, and the German company BioNTech which it has partnered with in the event of the shots, included 4,500 children aged six months to 12 years outdated.

Researchers discovered that members in the age group had six occasions transfer Covid combating antibodies one month after receiving the booster dose than that they had one month after the second dose.

While the booster is probably going to present additional safety towards an infection from U.S. children, some consultants imagine that children could also be positive with out this extra protection.

Deaths from Covid amongst children have been extraordinarily uncommon in the course of the pandemic thus far.

The CDC stories that 0.01 % of deaths from the virus over the previous two years have been among the many under-18 age group, regardless of 75 % having been contaminated with the virus – by far the very best prevalence.

‘The incontrovertible fact that 75 % of our children and adolescents in the U.S. have now been uncovered to Covid and have proof of [antibodies] is additional proof that booster shots are usually not wanted for this inhabitants,’ Dr Monica Ghandi, a prime infectious illness knowledgeable from the University of California, San Francisco advised on Tuesday.

‘Two shots are adequate to produce a powerful (long-lasting) [immune] response and pure an infection generates a long-lasting response.’

A examine from the University of Utah final year discovered that fifty % of pediatric Covid instances are asymptomatic. 

The examine was carried out earlier than the more-mild Omicron variant emerged, that means the chance for children to even really feel signs is probably going decrease now.

Children might also be much less seemingly to unfold the virus when contaminated, with a German examine discovering that they launch as little as solely 25 % of virus particles as adults do.

Data revealed by New York state officers on the finish of February additionally discovered that the shot was solely 12 % efficient at stopping Covid an infection for children aged five to 11.

Pfizer, which is forecasting round $30 billion in income this year from gross sales of the COVID-19 vaccine, additionally beforehand made a push to get a 3 dose vaccine for children six months to 4 years outdated earlier this year.

Those plans have since been halted. 

Currently, the company’s two-dose vaccine collection is offered to all Americans five and older. Those 12 and older are eligible for boosters, and a fourth general dose has been approved for all Americans 50 and older. 


Back to top button